Why the study?
Do acute-phase cardiovascular peptides predict short-term mortality and cardiogenic shock in patients with acute myocardial infarction?
Population
141 consecutive patients with acute myocardial infarction (AMI)
Design
Cohort
Follow-up
short-term
Authors
Loading...
Adrenomedullin may aid early risk stratification in AMI; leaves open its added value over existing scores and requires prospective validation.
Do acute-phase cardiovascular peptides predict short-term mortality and cardiogenic shock in patients with acute myocardial infarction?
High acute-phase plasma adrenomedullin concentration is a strong independent predictor of short-term mortality and cardiogenic shock in patients with acute myocardial infarction.
Katayama et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: